Navigation Links
Aposense Receives Frost & Sullivan Technology Innovation of the Year Award
Date:11/6/2008

MOUNTAIN VIEW, Calif., Nov. 6 /PRNewswire/ -- Frost & Sullivan today announced that the 2008 European Technology Innovation of the Year Award in molecular/cellular imaging has been bestowed upon Aposense Ltd., for its pioneering molecular platform for the targeting and imaging of apoptosis.

Israeli-based Aposense's technology platform, known as Aposense(R), is an innovative set of rationally designed molecules specifically targeting apoptosis (programmed cell death), both for medical imaging, personalised medicine, and for targeted drug design.

"The modular structure of Aposense(R) molecules allows a broad range of imaging moieties for clinical imaging to be attached and targeted to apoptotic cells," notes Frost & Sullivan Research Analyst Katherine Austin. "Drugs can also be targeted to apoptotic cells and tissues with Aposense(R). This important characteristic makes Aposense(R) technology applicable to various imaging modalities and targeted therapeutics."

The Aposense(R) lead-compound for molecular imaging, ML-10, enables real-time visualisation of biological activity in the clinic using a standard positron emission tomography (PET) scanner following radio-labeling of the ML-10 agent with the isotope 18-F, which is used for most other PET procedures. It can be used in the diagnosis of disease as well as disease staging, and also for monitoring response to therapy. It can also be integrated as a valuable tool in the drug development processes.

"In the field of oncology, Aposense(R) ML-10 allows clinicians to see response of tumors to anti-cancer treatment within hours or days, compared with the use of current technologies such as computerised tomography or magnetic resonance imaging, which require weeks or months before the therapeutic effects can be visualised," says Austin. "Standard imaging technologies reveal treatment effects only at the anatomical level, while with Aposense(R), the biological effect can be seen much earlier
'/>"/>

SOURCE Frost & Sullivan
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
5. IsoTis Receives FDA Clearance for Accell Family of Products
6. Actavis Receives Approval of Fentanyl Transdermal System in the U.S.
7. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
8. IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma
9. XTL Receives Staff Letter From NASDAQ
10. XTL Receives Staff Letter From NASDAQ; XTL may Transfer its ADR Listing to the NASDAQ Capital Market
11. Hemo-Stream(TM) Chronic Dialysis Catheter Receives FDA Clearance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... /CNW/ - Canada,s Research-Based Pharmaceutical Companies ... released report on Cost Drivers of Public Drug Plans in ... the report, the rates of change in drug costs have ... -0.8 percent in 2012/13 for a number of select public ... the costs of medicines without considering their overall impact on ...
(Date:4/1/2015)... Los Angeles, CA (PRWEB) April 01, 2015 ... portable reader that can read both chromatographic and fluorescent ... a leading supplier of high performance, quantitative readers and ... readers globally. The HRDR-400 is a first of its ... capabilities in one instrument. , Dr. Neven Karlovac, ...
(Date:4/1/2015)... recruitment firm Slone Partners is pleased to ... Sales at Optimal Medicine, an international digital health group ... over 20 years experience in healthcare information technology client ... Dell Services Healthcare, Medsphere Systems and McKesson. , ... accomplishing the goals Optimal Medicine had for this role,” ...
(Date:3/31/2015)... 2015 Eastern Kentucky University is ... bachelor’s of criminal justice degree programs by Nonprofitcollegesonline.com. ... inspiring ideas and high quality educational opportunities,” Editor ... University. We are confident that students will find ... is the site’s first “Students before Profits” list, ...
Breaking Biology Technology:Rx&D responds to PMPRB report: overall impact of medicines must always be considered 2Holomic to Introduce the First Dual, Chromatographic and Fluorescent Rapid Test Reader, the HRDR-400 2Slone Partners Fills Head of Sales at Optimal Medicine 2EKU Ranked in Top 50 Among Online Criminal Justice Degrees 2
... The medical imaging company SyntheticMR AB, ... order for their magnetic resonance imaging software from Umeå ... be used in clinical practice to monitor the treatment ... SyMRI Diagnostics, includes tools to automatically estimate a measure ...
... Verenium Corporation (Nasdaq: VRNM ), a leading ... of high-performance enzymes, today announced James Levine, President and ... Mr. Levine will present at the upcoming ... September 12, 2011.  The presentation is expected to begin ...
... Switzerland, September 1, 2011 Study Assessing ... in mid 2012 Kuros Biosurgery AG, a ... and bioactive-biomaterial combination products for trauma, wound and spinal ... a Phase IIb clinical trial designed to investigate KUR-211 ...
Cached Biology Technology:Swedish University Hospital Improves Monitoring of Treatment Efficacy in Multiple Sclerosis With Synthetic MRI Innovation 2Swedish University Hospital Improves Monitoring of Treatment Efficacy in Multiple Sclerosis With Synthetic MRI Innovation 3Verenium to Present at Upcoming Conferences 2Verenium to Present at Upcoming Conferences 3Kuros Completes Patient Recruitment in a Phase IIb Clinical Trial With KUR-211 for Diabetic Foot Ulcers 2Kuros Completes Patient Recruitment in a Phase IIb Clinical Trial With KUR-211 for Diabetic Foot Ulcers 3
(Date:3/20/2015)... , Mar. 20, 2015 Research and Markets ... addition of the "India Sensors Market Forecast ... The sensor market is projected to ... Consumer electronics, automotive, industrial and healthcare ... in the country. In addition, adoption of MEMS ...
(Date:3/20/2015)... , March 20, 2015 NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce ... wallet is one of the products featured in 2015 ... 20th at 11:00 PM EST on the DIY Network. ... Las Vegas , site of the ...
(Date:3/19/2015)...  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... mobile commerce market, announces its biometric payment technology, the Wocket® ... this week on Washington DC,s Fox ... segment "The Next Great Thing", host Laura Evans ... and ,a really big breakthrough in mobile payment.,  ...
Breaking Biology News(10 mins):India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3
... In 2005, the overall cost of patients' time spent on cancer ... to a new study in the January 3 issue of the ... for the 11 cancers studied and for different phases of cancer ... the direct medical costs of cancer care, but few have attempted ...
... the January issue of the journal Cell Metabolism, published by ... the formation of a poorly understood type of muscle. Moreover, ... IIX fibers were able to run farther and at higher ... ultimately lead to novel drugs designed to change the composition ...
... insect cells ?not in eggs, where flu vaccines currently available ... effective as conventional vaccines in protecting people against the flu, ... the Journal of the American Medical Association. , Removing eggs ... health officials seeking to protect the population from seasonal flu ...
Cached Biology News:Study calculates patient time costs associated with cancer care 2Study calculates patient time costs associated with cancer care 3'Marathon mice' elucidate little-known muscle type 2'Marathon mice' elucidate little-known muscle type 3Bypassing eggs, flu vaccine grown in insect cells shows promise 2Bypassing eggs, flu vaccine grown in insect cells shows promise 3
Chaperone Sampler Kit 10 mu g each...
... Solid phase reagent ... purification; Easy & unique ... Compatible with detergents and ... & recover non-envelop viruses ...
AMAP Multi Site-directed Mutagenesis Kit Research Focus: other Storage Temperature: -20C Shipping Temperature: dry ice...
Umbilical cord blood mesenchymal stem cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood Progenitor Cells...
Biology Products: